Retraction Watch

Bribery offers from China rattle journal editors. Are they being scammed?

On November 12, Richard Addante, an associate editor at the journal Frontiers in Psychology, received an alarming email from someone purporting to be a faculty member at a university in China.

“I have a lot of papers to publish, papers on computers, medicine, materials, and so on,” the email, signed by a “Wei Yang” of Zhengzhou College of Business and Industry, stated. “If you can help me publish my paper, I’ll pay you $1500 as a referral fee.”

To Addante, a psychologist at Florida Institute of Technology, in Melbourne, the message suggested the field of scientific publishing needed a thorough clean-up.

19 months and counting: Former Hindawi journal still hasn’t marked paper

A journal formerly published by Hindawi has yet to publish any sort of notice on a paper sleuths reported for containing duplicated images 1.5 years ago.

According to Kevin Patrick, the sleuth who contacted the publisher in mid-2023, the episode “might be a useful case study” of the issues facing Wiley, which acquired Hindawi in 2021 and stopped using the brand name earlier this year after retracting thousands of papers and closing journals overrun by paper mills.

The article, “Resveratrol Derivative, Trans-3, 5, 4 ′-Trimethoxystilbene Sensitizes Osteosarcoma Cells to Apoptosis via ROS-Induced Caspases Activation,” appeared in Oxidative Medicine and Cellular Longevity in 2021. Clarivate removed the journal from its Web of Science index in March 2023 for failing to meet quality criteria.

In April 2023, Elisabeth Bik left a comment on PubPeer, noting “several figures in this paper look identical to figures in a 2019 paper by some of the same authors,” which had been retracted. “I could not find wording about e.g. a republication of part of that study, and the 2019 paper is not included in the references,” she wrote.

Dean in Bulgaria accused of plagiarism

Earlier this year, Milen Zamfirov, dean of the faculty of educational sciences at Sofia University in Bulgaria, was named an exceptional scientist in the social sciences and humanities. As part of the accolades at the prestigious Pythagoras Science Awards from the Bulgarian Ministry of Education and Science, Zamfirov received a commemorative plaque, diploma, and a cash prize of 8,000 BGN (US $4,300).

Now, he is accused of plagiarising past research in a paper he co-authored with Margarita Bakracheva, who received a certificate of excellence from the Union of the Bulgarian Scientists earlier this year.

Their study, titled, “In Search of Integrativity of Sciences: the Principle of Supplementarity in the Story of Pauli and Jung,” was published in Bulgarian in 2021.

But the paper seems to have significant overlap with other sources, according to Irene Glendinning, a researcher and consultant based in Leicester, UK.

Former Harvard researcher, now at Moderna, loses paper following postdoc’s report

PLOS Pathogens has retracted a paper by a former group at Harvard following a postdoc’s allegations the work contained manipulated data.

The retracted paper, “Pseudomonas aeruginosa–induced nociceptor activation increases susceptibility to infection,” appeared in 2021 from the lab of Mihaela Gadjeva, an immunologist previously based at Brigham and Women’s Hospital and Harvard Medical School in Boston. It has been cited 22 times, according to Clarivate’s Web of Science.

According to her LinkedIn profile, Gadjeva had been employed at Brigham and Women’s hospital for 16 years until her departure at some point in 2022. Since then, she has been an associate director of bacteriology at Moderna.

Weekend reads: A misconduct advent calendar; false affiliation scam ends; RW in Canada’s Parliament

Dear RW readers, can you spare $25?

The week at Retraction Watch featured:

Our list of retracted or withdrawn COVID-19 papers is up past 450. There are more than 50,000 retractions in The Retraction Watch Database — which is now part of Crossref. The Retraction Watch Hijacked Journal Checker now contains more than 300 titles. And have you seen our leaderboard of authors with the most retractions lately — or our list of top 10 most highly cited retracted papers? What about The Retraction Watch Mass Resignations List — or our list of nearly 100 papers with evidence they were written by ChatGPT?

Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):

Science places expressions of concern on two articles as Toronto’s Sinai Health investigates

Science has issued expressions of concern for two articles from the lab of Daniel Durocher, a professor of molecular genetics at the University of Toronto.

The notices, and two more editor’s notes on Nature articles, follow PubPeer comments on several of Durocher’s papers pointing out potentially duplicated images, as described by ForBetterScience. Durocher has responded to many of the comments promising to look into the issues.

Besides his academic positions at Toronto and the Lunenfeld-Tanenbaum Research Institute at Sinai Health, Durocher co-founded Repare Therapeutics, a biotech company with five ongoing clinical trials of potential treatments for cancer.

The two Science articles, “Mitosis inhibits DNA double-strand break repair to guard against telomere fusions” from 2014, and “Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase,” from 2007, together have been cited nearly 1,000 times, according to Clarivate’s Web of Science.

Wiley medical journal retracts dozens of papers for manipulated peer review, with more to come

International Wound Journal, a Wiley title, has retracted 27 papers since June with notices mentioning “manipulated” or “compromised” peer review.

“A comprehensive investigation examining manipulated peer review in this journal is in progress,” a Wiley spokesperson told Retraction Watch. The publisher anticipates retracting more articles as the investigation continues.

The first retraction of the batch, of the November 2023 article “Analysis of the Association Between Serum Levels of 25(OH)D, Retinol Binding Protein, and Cyclooxygenase-2 and the Disease Severity in Patients with Diabetic Foot Ulcers,” appeared June 14. The notice stated Wiley and the journal’s editor in chief “concluded that the peer review process of this article was manipulated” following an investigation by the publisher.

Crossref suspends company’s membership after Retraction Watch report

Crossref, a nonprofit focused on metadata of scholarly publications, has suspended the membership of a company linked to websites which copied the appearance of journals belonging to Elsevier and Springer Nature, among others from major publishers, Retraction Watch has learned.

The move follows Anna Abalkina’s reporting on Retraction Watch about the activities of Springer Global Publications, which had used its membership in Crossref to assign Digital Object Identifiers (DOIs) to papers in 13 journals with similar names to those established by legitimate publishers. The DOIs linked to papers on webpages mimicking the appearance of the original journals.

Springer Global Publications did not immediately respond to our request for comment on the suspension of its Crossref membership. The company previously told us it did not “create, review, or manage the content associated with the identifiers we issue,” and did not publish any journals.

The website of the company has also been suspended by its hosting provider, and is no longer available online.

Weekend reads: Cassava’s Alzheimer’s drug fails; new journal hijacking scam; Hong Kong academic jailed

Giving Tuesday is coming up. Would you consider a donation to support Weekend Reads, and our daily work?

The week at Retraction Watch featured:

Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):

Cancer researcher admitted faking data

A former researcher at Nemours Children’s Health in Wilmington, Del., admitted to falsifying and incorrectly reporting data in at least two published studies, both of which were supported by grants from the National Institutes of Health. The studies have been retracted.

The researcher, Valerie Sampson, reported herself to Nemours, which launched an inquiry into all of her publications, according to a hospital spokesperson. The institution’s findings are under review at the U.S. Office of Research Integrity.

Sampson left Nemours in January 2022 after 16 years with the hospital, according to her LinkedIn profile. She also held a position as an affiliated scientist at the University of Delaware, a role that ended in the same month, per the profile. Six months following her departure from Nemours, Sampson took a position as a scientist at WuXi Advanced Therapies in Philadelphia, a company specializing in cell and gene therapies, for a little over a year. She is currently unemployed, according to the profile.

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: